Provista is Bioscience Company of the Year
Testing Technologies for Central Nervous
System Disorders
Today, Provista Life Sciences offers two innovative, affordable types of tests to aid doctors and patients in the detection of one of the most debilitating CNS disorders facing our aging population: Alzheimer’s disease.
The
LymPro Test® is a breakthrough blood test designed to work in conjunction with traditional diagnostic methods to help doctors develop a more timely and accurate diagnosis of Alzheimer’s disease.
In addition to this test, Provista Life Sciences is dedicated to further research into
Central Nervous System (CNS) diseases, with a goal of improving the care and quality of life for people suffering from memory loss and cognitive impairment.